<DOC>
	<DOCNO>NCT00544180</DOCNO>
	<brief_summary>To determine satisfaction subject Actonel 35 mg Once Week treatment post-menopausal osteoporosis . Open , non-controlled , multi-center study .</brief_summary>
	<brief_title>ROSPA - Record Satisfaction Patients With Actonel 35 mg Once Week</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<criteria>Inclusion criterion : Postmenopausal ambulatory woman Established osteoporosis Exclusion criterion : History cancer : basal cell squamous cell carcinomadocumented 6month remission , Diagnosis hypocalcemia , hyperparathyroidism , hyperthyroidism The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>